Clinical information
Please be advised: Alberta Health Services is the primary source for COVID-19 information and hosts clinical resources for all providers, including those in primary care. Visit Ahs.ca/covid for resources.
The Alberta Health website is also a great resource, which includes official updates from the Chief Medical Officer, Dr. Deena Hinshaw, and actions being taken to protect the health of Albertans.
As the COVID-19 pandemic evolves, this page will focus on linking to key sources of information from content experts.
New Clinical Updates
- May 26: Evusheld now offered for prevention of COVID-19
Evusheld is now being offered for prevention of COVID-19, to Albertans who are highly immunocompromised. Health care provider FAQ; Patients FAQ - May 13: Paxlovid™ treatment: Updates on rebound symptoms and long COVID
Letter to Alberta physicians from the Office of the Chief Medical Officer of Health - May 12: Paxlovid™ eligibility criteria expanded
Criteria has been expanded to include two additional groups: Those who have received two doses of vaccine and are age 60+ (50+ if indigenous) with one pre-existing condition; and those who have received three or more doses of vaccine and are age 70+ (60+ if indigenous) with two or more pre-existing conditions.
Community Physicians
Outpatient Treatments for COVID-19
- Paxlovid Practitioner Prescription Template
This practitioner prescription can be used when prescribing Paxlovid to patients. It can also be used as a companion sheet to send along with an EMR-generated prescription to let the pharmacist know interactions and eligibility have been addressed. - Step-by-step Paxlovid prescribing guide
A resource from ACFP to help physicians get started prescribing Paxlovid. - Outpatient treatment for COVID-19
Information and resources on available outpatient treatments for COVID-19. - Paxlovid™ availability in pharmacies
Since not all pharmacies in Alberta are handling Paxlovid, prescribers are responsible for confirming that the pharmacy they are sending a prescription to is dispensing Paxlovid and have it in stock. If a pharmacy receives a prescription for Paxlovid and is unable to fill it, the pharmacy is responsible for identifying another pharmacy that can fill the prescription. This map can be used to verify which pharmacies in your community are dispensing Paxlovid.
Patient Care & Your Practice
- COVID 19 Guidance for Community Providers
Provincial PCN Committee - COVID Task Group has produced a COVID-19 guidance document for community providers. The simplified guidance provides advice for clinics in managing common questions about testing and navigating COVID. - Advice and template to support doctor's note requests from patients for travel
Advice and a letter template are provided to support clinics receiving requests for a doctor's note for the purpose of international travel. - COVID-19 Information for Community Physicians
The primary source of information on COVID-19 specific to community physicians and their teams. Includes guidance and pathways. - COVID-19 immunization for children under 12
AHS web page with resources and information on COVID-19 immunization for children under 12. - Patient Care and Testing FAQs
Resource from AHS - AHS Immunization FAQ – for Community Physicians
Resource from AHS - Be a Vaccine Positive Clinic - Toolkit
Resource from the AMA with tools and information on addressing vaccine hesitancy and providing vaccinations in community practice.
Infection Prevention & Control
- COVID-19 FAQ on Infection Prevention and Control and Exposure for Community Physicians
FAQs from AHS on immunization topics
Evidence Reviews
- AHS Rapid Review: Ivermectin Evidence Review Update
The AHS Scientific Advisory Group and the COVID-19 Therapeutics Working Group continue to monitor new evidence on ivermectin. After review there continues to be insufficient evidence of benefit and the previous recommendations continue to be upheld. October 5, 2021. - AHS Rapid Review: Likelihood of Transmission of COVID-19 infection after COVID-19 Vaccination
Although studies suggest that it is overall rare for vaccinated people to spread COVID-19 infection, it is possible. Vaccinated people should still follow public health measures in place. October 21, 2021. - PEER Tools for Practice: Long COVID: A (somewhat) short summary of risks, symptoms and natural course
The presence of Long COVID (persistence of ≥1 symptom after acute infection) is found in 20-80% at 60 days post-infection, varying widely based on study design and population. Fatigue, dyspnea and cognitive effects are the most common symptoms. September 20, 2021 - Scientific Advisory Group COVID-19 Recommendations
View more evidence reviews on the AHS website.
Hospital-Based Physicians
- COVID-19 Information for AHS Staff and Health Professionals
AHS information page
Contact us
See outdated information? Clicked on a broken link? Get in touch with us at webmaster@albertadoctors.org.
